Characteristics of South African patients presenting with kidney disease in rural KwaZulu-Natal: a cross sectional study
Tóm tắt
Diabetes mellitus is the leading cause of end-stage renal disease (ESRD) globally. Diabetes and human immunodeficiency virus (HIV), both prevalent in South Africa, have not been reported as significant causes of ESRD. We evaluated chronic kidney disease (CKD) and cardiovascular disease risk factors in a cross-sectional study of 302 patients (165 females/ 137 males) at a CKD clinic in rural northern KwaZulu-Natal. We included all CKD outpatient clinic attendees and excluded acute renal failure patients. Demographic, clinical and laboratory data collected were analyzed with Stata11 software. Logistic regression analysis was used to determine factors associated with advanced CKD and results expressed as the odds ratio with the 95% confidence interval [OR (95% CI)]. Of 302 patients analyzed, 290 (96%) were black African. Mean age ± SD was 47.1 ± 17.0 years. Approximately 86.4% of females and 54.5% of males were overweight/ obese. Dyslipidaemia was observed in 47.9% females and 29.2% males (P < 0.001). Estimated glomerular filtration rate (eGFR) was <30 ml/min/1.73 m2 in 50.6% patients. CKD risk factors observed were: hypertension (77.8%), diabetes (29.8%), HIV (28.5%), glomerulonephritis (7.0%) and tubulointerstitial diseases (5.6%). Independent factors associated with eGFR <30 ml/min/1.73 m2 at presentation were: HIV [OR = 2.4 (1.3-4.2), P = 0.004] and hypertension [OR = 2.3 (1.3-4.2), P = 0.007]. Diabetes and HIV are prevalent in CKD patients at primary/regional level healthcare in South Africa. With registry data lacking, dedicated CKD clinics at lower healthcare levels may provide valuable data on CKD epidemiology including changes in aetiology. Primary healthcare practitioners are faced with advanced CKD patients in resource-poor settings, with limited opportunity for upward referral hence the need for nephrology outreach programs.
Tài liệu tham khảo
Naicker S: End-stage renal disease in sub-Saharan and South Africa. Kidney Int. 2003, 63 (Suppl 83): 119-122.
Atkins RC, Zimmet P: Diabetic kidney disease: act now or pay later. Acta Diabetol. 2010, 47: 1-4.
Puoane T, Steyn K, Bradshaw D, Laubscher R, Fourie J, Lambert V, Mbananga N: Obesity in South Africa: the South African demographic and health survey. Obes Res. 2002, 10 (10): 1038-1048.
Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D: The burden of non-communicable diseases in South Africa. Lancet. 2009, 374: 934-947.
Moosa MR, Kidd M: The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int. 2006, 70 (6): 1107-1114.
South African Renal Society, South African Transplant Society, Southern African HIV Clinicians Society: Guidelines for renal replacement therapy in HIV-infected individuals in South Africa. S Afr J HIV Med. 2008, 9 (2): 34-42.
Weiner DE: Public health consequences of chronic kidney disease. Clin Pharmacol Ther. 2009, 86 (5): 566-569.
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention. Circulation. 2003, 108: 2154-2169.
Dirks JH, De Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje D, Katz IJ, Naicker S, Rodriguez-Iturbe B, Schieppati A, Shaheen F, Sitthi-Amorn C, Solez K, Viberti G, Remuzzi G, Weening JJ, International Society of Nephrology Commission for the Global Advancement of Nephrology Study Group 2004: Prevention of chronic kidney and vascular disease: toward global health equity - The Bellagio 2004 Declaration. Kidney Int. 2005, 68 (Suppl 98): S1-S6.
Hallan SI, Stevens P: Screening for chronic kidney disease: which strategy?. J Nephrol. 2010, 23 (02): 147-155.
Smith JM, Mott SA, Hoy WE, International Federation of Kidney Foundations: Status of chronic kidney disease prevention programs: international Federation of Kidney Foundation Members 2005/2007. Kidney Int. 2008, 74 (12): 1516-1525.
Katz I, Schneider H, Shezi Z, Mdleleni G, Gerntholtz T, Butler O, Manderson L, Naicker S: Managing type 2 diabetes in Soweto–The South African chronic disease outreach program experience. Prim Care Diabetes. 2009, 3 (3): 157-164.
Statistics South Africa: Provincial profile - KwaZulu-Natal. Report No. 00-91-052004. http://www.statssa.gov.za/publications/Report-00-91-05/Report-00-91-052004.pdf (Accessed 21st January 2014)
Monticelli F, Day C, Barron P: District health baromater 2007/2008. Indicator comparisons by district: socio-economic indicators. http://www.hst.org.za/uploads/files/dhb0708_sec1.pdf (Accessed 29th January 2013)
Levey AS, Stevens LA, Schmid CH: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612.
Schwartz GJ, Haycock GB, Edelman CM, Spitzer A: A simple estimation of glomerular filtration rate in children derived from body weight and plasma creatinine. Pediatrics. 1976, 58: 259-263.
Van Deventer HE, George JA, Paiker JE, Becker PJ, Katz IJ: Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations. Clin Chemistry. 2008, 54 (7): 1197-1202.
Eastwood JB, Kerry SM, Plange-Rhule J, Micah FB, Antwi S, Boa FG, Banerjee D, Emmett L, Miller MA, Cappuccio FP: Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations. Nephrol Dial Transplant. 2010, 25 (7): 2178-2187.
Madala ND, Nkwanyana N, Dubula T, Naiker IP: Predictive performance of eGFR equations in South Africans of African and Indian ancestry compared with (99 m)Tc-DTPA imaging. Int Urol Nephrol. 2012, 44 (3): 847-855.
van Rensburg BW, van Staden AM, Rossouw GJ, Joubert G: The profile of adult nephrology patients admitted to the Renal Unit of the Universitas Tertiary Hospital in Bloemfontein, South Africa from 1997 to 2006. Nephrol Dial Transplant. 2010, 25 (3): 820-824.
Okpechi I, Swanepoel C, Duffield M, Mahala B, Wearne N, Alagbe S, Barday Z, Arendse C, Rayner B: Patterns of renal disease in Cape Town South Africa: a 10-year review of a single-centre renal biopsy database. Nephrol Dial Transplant. 2011, 26 (6): 1853-1861.
Han TM, Naicker S, Ramdial PK, Assounga AGH: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 2006, 69 (12): 2243-2250.
Navaneethan SD, Aloudat S, Singh S: A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol. 2008, 9: 3-
Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL: Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008, 121 (4): 332-340.
Peer N, Steyn K, Dennison CR, Levitt NS, Nyo MT, Nel JH, Commerford PJ, Fourie JM, Hill MN: Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi-Hi study. Am J Hypertens. 2008, 21 (8): 896-902.
Gold CH, Isaacson C, Levin J: The pathological basis of end-stage renal disease in blacks. S Afr Med J. 1982, 61 (8): 263-265.
Seedat YK, Naicker S, Rawat R, Parsoo I: Racial differences in the causes of end-stage renal failure in Natal. S Afr Med J. 1984, 65 (24): 956-958.
Veriava Y, du Toit E, Lawley CG, Milne FJ, Reinach SG: Hypertension as a cause of end-stage renal failure in South Africa. J Hum Hypertens. 1990, 4 (4): 379-383.
Arogundade FA, Barsoum RS: CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis. 2008, 51 (3): 515-523.
Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD: Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008, 197 (11): 1548-1557.
Alebiosu CO, Ayodele OE: The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria. Trop Dr. 2006, 36: 218-219.
Karaye KM, Habib AG: Dyslipidaemia in patients with established cardiovascular disease in Sub-Saharan Africa: a systematic review and meta-analysis. Eur J Prev Cardiol. 2012, Epub 2012 September 5. Pubmed PMID: 22952291
Harper CR, Jacobson TA: Managing dyslipidemia in chronic kidney disease. J Am Coll Cardiol. 2008, 51 (25): 2375-2384.
Murthy K, Stevens LA, Stark PC, Levey AS: Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. Kidney Int. 2005, 68 (4): 1884-1887.
Eppenga W, van Luin M, Richter C, Derijks H, De Smet P, Wensing M: The validity of the modification of diet in renal disease formula in HIV-infected patients: a systematic review. J Nephrol. 2014, 27 (1): 11-18.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/15/61/prepub